Tag: Adjuvant durvalumab therapy

Home / Adjuvant durvalumab therapy

Categories

Neoadjuvant/adjuvant durvalumab is approved by the USFDA for resectable non-small cell lung cancer

August 2024: The Food and Drug Administration has granted approval for the use of durvalumab (Imfinzi, AstraZeneca) in combination with platinum-containing chemotherapy as a neoadjuvant treatment, fol...
adjuvant-durvalumab-therapy

Scan the code